跳至主要内容
临床试验/NCT05667350
NCT05667350招募中不适用

Exploration and Validation of a Diagnosis Model for Biliary Tract Cancer Based on Combined Liquid Biopsy in Peripheral Blood: A Multi-center Prospective Study

Eastern Hepatobiliary Surgery Hospital2 个研究点 分布在 1 个国家目标入组 492 人开始时间: 2022年2月28日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
492
试验地点
2
主要终点
The sensitivity and specificity of the combined model in detection of biliary tract cancers.

研究概览

简要总结

ASCEND-BTC is a prospective, multi-center, observational study aimed at detecting early biliary tract cancer by combined assays of serum protein and cell-free DNA (cfDNA) methylation. The study will enroll approximately 492 participants diagnosed with biliary tract cancer and benign diseases.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
40 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

The sensitivity and specificity of the combined model in detection of biliary tract cancers.

时间窗: 24 months

次要结局

  • The sensitivity and specificity of the combined model in detection of different stages of biliary tract cancers.(24 months)
  • The sensitivity and specificity of the combined model in detection of different subtypes of biliary tract cancers.(24 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Xiaoqing Jiang

Director

Eastern Hepatobiliary Surgery Hospital

研究点 (2)

Loading locations...

相似试验